Trial reportFrontiers in medicine2025
Optimal programmed intermittent epidural bolus volume for dural puncture epidural labor analgesia in patients with gestational hypertension: a biased-coin up-and-down sequential allocation trial.
Trial report in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to evaluate the effective programmed intermittent epidural bolus (PIEB) volume and the efficacy of dural puncture epidural (DPE) for labor analgesia in patients with gestational hypertension (GH). Methods: Fifty primiparous women with GH, aged 22-40 years and classified as American Society of Anesthesiologists physical status II, scheduled for DPE labor analgesia were included. A biased-coin up-and-down sequential method was used to determine bolus volumes (7-12 mL). The first patient received 7 mL, with subsequent adjustments based on the need for rescue analgesia within 6 h of initiation or full cervical dilation. The truncated Dixon and Mood method and isotonic regression analysis were employed to calculate the 90% effective PIEB volume (EV90) and 95% confidence interval (CI). Recorded parameters included maximum sensory and motor blockade scores, mean arterial pressure, adverse events, and neonatal outcomes (umbilical artery pH, Apgar scores at 1 and 5 min). Results: The EV90 was 9.82 (95% CI: 9.41-10.23) mL using the truncated Dixon and Mood method and 9.95 (95% CI: 9.52-10.38) mL using isotonic regression. The incidence of sensory blockade ≥T6 increased with higher volumes: 0% (7-9 mL), 13.33% (10 mL), 25.00% (11 mL), and 60.00% (12 mL). In the 12 mL group, one case of Bromage grade 1 motor blockade (recovered within 6 h), one of fetal bradycardia (resolved after maternal repositioning), and two cases of hypotension not requiring treatment were observed. No significant intergroup differences were detected in the duration of the first or second stage of labor or in the use of antihypertensive medications ( Conclusion: For patients with GH receiving DPE with PIEB (40-min interval; 0.08% ropivacaine + 0.3 μg/mL sufentanil), the EV90 was 9.89 mL. This regimen significantly reduced the risk of excessive sensory block and hypotension while ensuring effective analgesia. Clinical trial registration: www.chictr.org.cn, identifier ChiCTR2500099107.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.